Same experience here with MASH prevalence in GLP-1. anders_CPH described it perfectly.
+1 to DebRD_ATL. Especially the point about "I know it is not exactly on-topic but it..." — I have seen the same in my own experience with MASH prevalence in GLP-1.
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGL Biochem (Shanghai) Ltd. — Direct Manufacturer
Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.
Browse GL BiochemSlightly tangential to MASH prevalence in GLP-1 but paige_pharma reminded me — does anyone have experience combining this with metformin?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
Yep. My endo said the same thing about MASH prevalence in.